102 related articles for article (PubMed ID: 1468500)
1. Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects.
Gicquel S; Mazarguil H; Allard M; Simonnet G; Zajac JM
Eur J Pharmacol; 1992 Nov; 222(1):61-7. PubMed ID: 1468500
[TBL] [Abstract][Full Text] [Related]
2. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats.
Million M; Fioramonti J; Gicquel S; Zajac JM; Bueno L
J Pharmacol Exp Ther; 1993 Apr; 265(1):96-102. PubMed ID: 8474035
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus.
Dupouy V; Zajac JM
Eur J Pharmacol; 1997 Jul; 330(2-3):129-37. PubMed ID: 9253945
[TBL] [Abstract][Full Text] [Related]
4. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis.
Dupouy V; Zajac JM
Regul Pept; 1995 Nov; 59(3):349-56. PubMed ID: 8577940
[TBL] [Abstract][Full Text] [Related]
5. A new series of photoactivatable and iodinatable linear vasopressin antagonists.
Carnazzi E; Aumelas A; Barberis C; Guillon G; Seyer R
J Med Chem; 1994 Jun; 37(12):1841-9. PubMed ID: 8021923
[TBL] [Abstract][Full Text] [Related]
6. Effects of F8Famide analogs on intestinal transit in mice.
Gicquel S; Fioramonti J; Bueno L; Zajac JM
Peptides; 1993; 14(4):749-53. PubMed ID: 8234020
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat.
Gouardères C; Sutak M; Zajac JM; Jhamandas K
Eur J Pharmacol; 1993 Jun; 237(1):73-81. PubMed ID: 8102975
[TBL] [Abstract][Full Text] [Related]
8. Central effects of neuropeptide FF on intestinal motility in naive and morphine-dependent rats.
Gelot A; Fioramonti J; Zajac JM; Bueno L
Neuropeptides; 1995 Nov; 29(5):245-50. PubMed ID: 8587659
[TBL] [Abstract][Full Text] [Related]
9. Biochemical, cellular and pharmacological activities of a human neuropeptide FF-related peptide.
Gelot A; Mazarguil H; Dupuy P; Francés B; Gouardères C; Roumy M; Zajac JM
Eur J Pharmacol; 1998 Aug; 354(2-3):167-72. PubMed ID: 9754917
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide FF, pain and analgesia.
Roumy M; Zajac JM
Eur J Pharmacol; 1998 Mar; 345(1):1-11. PubMed ID: 9593588
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice.
Kavaliers M
Neurosci Lett; 1990 Jul; 115(2-3):307-12. PubMed ID: 2234508
[TBL] [Abstract][Full Text] [Related]
12. Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain.
Rothman RB; Brady LS; Xu H; Long JB
Peptides; 1993; 14(6):1271-7. PubMed ID: 8134310
[TBL] [Abstract][Full Text] [Related]
13. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice.
Gelot A; Francés B; Gicquel S; Zajac JM
Eur J Pharmacol; 1998 Oct; 358(3):203-6. PubMed ID: 9822885
[TBL] [Abstract][Full Text] [Related]
15. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
Gouardères C; Jhamandas K; Sutak M; Zajac JM
Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
[TBL] [Abstract][Full Text] [Related]
16. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice.
Gelot A; Francés B; Roussin A; Latapie JP; Zajac JM
Brain Res; 1998 Oct; 808(2):166-73. PubMed ID: 9767158
[TBL] [Abstract][Full Text] [Related]
17. Identification of neuropeptide FF-related peptides in rodent spinal cord.
Bonnard E; Burlet-Schiltz O; Francés B; Mazarguil H; Monsarrat B; Zajac JM; Roussin A
Peptides; 2001 Jul; 22(7):1085-92. PubMed ID: 11445238
[TBL] [Abstract][Full Text] [Related]
18. A-18-famide and F-8-famide, endogenous mammalian equivalents of the molluscan neuropeptide FMRFamide (Phe-Met-Arg-Phe-NH2), inhibit colonic bead expulsion time in mice.
Raffa RB; Jacoby HI
Peptides; 1989; 10(4):873-5. PubMed ID: 2587427
[TBL] [Abstract][Full Text] [Related]
19. IgG from antiserum against endogenous mammalian FMRF-NH2-related peptides augments morphine- and stress-induced analgesia in mice.
Kavaliers M; Yang HY
Peptides; 1989; 10(4):741-5. PubMed ID: 2587416
[TBL] [Abstract][Full Text] [Related]
20. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs.
Gouardères C; Sutak M; Zajac JM; Jhamandas K
Eur J Pharmacol; 2000 Oct; 406(3):391-401. PubMed ID: 11040346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
